显微手术与立体定向放射外科治疗脑动静脉畸形的匹配队列研究
该回顾性匹配队列研究比较显微手术(MS)与立体定向放射外科(SRS)治疗脑动静脉畸形的疗效。匹配后每组各59例,主要终点(无新发永久性神经功能缺损的畸形血管团闭塞)两组均为69%。MS组闭塞率更高(98% vs 72%,P=0.001),但新发永久性神经功能缺损率也更高(31% vs 10%,P=0.011);SRS组治疗后出血率更高(10% vs 0%,P=0.027)。在破裂和未破裂动静脉畸形亚组分析中,主要终点无显著差异。
要点
- 匹配后MS与SRS组主要终点(无新发永久性神经功能缺损的闭塞)均为69%。
- MS组闭塞率98% vs SRS组72%(P=0.001),MS组更高。
- MS组新发永久性神经功能缺损率31% vs SRS组10%(P=0.011),MS组更高。
核心结论
- 对于特征匹配的脑动静脉畸形患者,MS与SRS提供相似的无神经功能缺损闭塞率。
- MS组畸形血管团闭塞更常实现,但新发永久性神经功能缺损风险更高。
研究设计与样本
- 回顾性匹配队列研究,评估机构数据库中接受MS和SRS治疗的脑动静脉畸形患者。
- MS治疗患者按患者和动静脉畸形特征以1:1比例与SRS治疗患者匹配。
- 匹配后MS和SRS队列各59例患者。
- 主要终点为无新发永久性神经功能缺损的动静脉畸形闭塞。
主要发现
- SRS组影像学随访(85 vs 11个月;P<0.001)和临床随访(92 vs 12个月;P<0.001)均显著长于MS组。
- 主要终点在两组均达到69%。
- MS组闭塞率显著更高(98% vs 72%;P=0.001)。
- MS组新发永久性神经功能缺损率显著更高(31% vs 10%;P=0.011)。
- SRS组治疗后出血率显著更高(SRS组10% vs MS组0%;P=0.027)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microsurgery (MS) and stereotactic radiosurgery (SRS) remain the preferred interventions for the curative treatment of brain arteriovenous malformations (AVM), but their relative efficacy remains incompletely defined. OBJECTIVE: To compare the outcomes of MS to SRS for AVMs through a retrospective, matched cohort study. METHODS: We evaluated institutional databases of AVM patients who underwent MS and SRS. MS-treated patients were matched, in a 1:1 ratio based on patient and AVM characteristics, to SRS-treated patients. Statistical analyses were performed to compare outcomes data between the 2 cohorts. The primary outcome was defined as AVM obliteration without a new permanent neurological deficit. RESULTS: The matched MS and SRS cohorts were each comprised of 59 patients. Both radiological (85 vs 11 mo; P < .001) and clinical (92 vs 12 mo; P < .001) follow-up were significantly longer for the SRS cohort. The primary outcome was achieved in 69% of each cohort. The MS cohort had a significantly higher obliteration rate (98% vs 72%; P = .001), but also had a significantly higher rate of new permanent deficit (31% vs 10%; P = .011). The posttreatment hemorrhage rate was significantly higher for the SRS cohort (10% for SRS vs 0% for MS; P = .027). In subgroup analyses of ruptured and unruptured AVMs, no significant differences between the primary outcomes were observed. CONCLUSION: For patients with comparable AVMs, MS and SRS afford similar rates of deficit-free obliteration. Nidal obliteration is more frequently achieved with MS, but this intervention also incurs a greater risk of new permanent neurological deficit.
引用
- Chen CJ, Ding D, Wang TR, et al. Microsurgery Versus Stereotactic Radiosurgery for Brain Arteriovenous Malformations: A Matched Cohort Study. Neurosurgery. 2019. PMID: 29762746. doi:10.1093/neuros/nyy174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。